Real-world evaluation of an acceptance and commitment therapy-based group programme for breast cancer survivors with fear of cancer recurrence

被引:2
|
作者
Sinclair, Fiona [1 ]
Gillanders, David [2 ]
Rooney, Natalie [3 ]
Bonathan, Christine [1 ]
Hendry, Kirsty [4 ]
McLoone, Philip [4 ]
Hewitt, Christopher [5 ]
机构
[1] NHS Greater Glasgow & Clyde, Glasgow, Scotland
[2] Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Scotland
[3] Maggies Forth Valley, Larbert, Scotland
[4] Univ Glasgow, Sch Hlth & Wellbeing, Glasgow, Scotland
[5] NHS Lothian, Edinburgh, Scotland
关键词
Breast cancer; Fear of cancer recurrence; Acceptance and commitment therapy; Patient support; Group support; COMPREHENSIVE ASSESSMENT; PREVALENCE; VALIDATION; VALIDITY;
D O I
10.1007/s00520-023-08179-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To evaluate the effectiveness and acceptability of a 6-week acceptance and commitment therapy (ACT)-based group programme on participants' fear of cancer recurrence (FCR), quality of life (QoL), psychological distress and psychological flexibility at the end of the programme and 12-week follow-up.Methods A one-group, post-test service evaluation of a real-world psychological programme was carried out to evaluate collected outcome measures and attendance for a total of 21 groups facilitated between 2017 and 2019. Participants were breast cancer survivors who attended a 6-week group programme led by NHS clinicians. Descriptive statistics and repeated measures ANOVA analyses were carried out for each outcome measure. Attendance levels were examined to assess acceptability.Results A total of 97 group participants who had completed curative treatment for breast cancer took part. Of whom, 89% completed at least 4 of the 6 weekly group sessions and 76% attended the 12-week follow-up session. Eighty-four (87%) participants returned outcome measures at all three time points relative to group participation (T1 = pre, T2 = post T3 = 12-week follow-up). Group participants were female, mean age 51.9 years. FCR was highest at T1 (mean 25.2, SD 4.7), reduced T2 (mean 21.2, SD 5.4) and further lowered T3 (mean 19.5, SD 6.2). This difference was statistically significant (p < 0.001). QoL was lowest at T1 (mean 62.4, SD 15.7), increased T2 (mean 71.7, SD 18.1) and further increased at T3 (mean 75.9, SD 17.5). This difference was statistically significant (p < 0.001). Psychological distress measures were shown to reduce, and psychological flexibility increased.Conclusions This real-world evaluation of an ACT-based group programme led to improvements in FCR, QoL, psychological distress and psychological flexibility in this population. This evaluation provides basis for further investigation to determine if these results can be replicated by controlled research design across diverse populations.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Real-world evaluation of an acceptance and commitment therapy–based group programme for breast cancer survivors with fear of cancer recurrence
    Fiona Sinclair
    David Gillanders
    Natalie Rooney
    Christine Bonathan
    Kirsty Hendry
    Philip McLoone
    Christopher Hewitt
    Supportive Care in Cancer, 2023, 31
  • [2] WiLLoW: An Acceptance and Commitment Therapy Intervention for Breast Cancer Survivors to Address Anxiety, Worry and Fear of Cancer Recurrence
    Shumay, Dianne
    Fujiye, Maria Therese
    Berman, Molly
    Gregg, Jennifer
    Melisko, Michelle
    Dunn, Laura
    PSYCHO-ONCOLOGY, 2013, 22 : 26 - 27
  • [3] MEDIATORS OF ACCEPTANCE AND COMMITMENT THERAPY FOR FEAR OF CANCER RECURRENCE
    Secinti, Ekin
    Mosher, Catherine E.
    Wu, Wei
    Stutz, Patrick V.
    Johns, Shelley A.
    ANNALS OF BEHAVIORAL MEDICINE, 2020, 54 : S496 - S496
  • [4] Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial
    Johns, Shelley A.
    Stutz, Patrick, V
    Talib, Tasneem L.
    Cohee, Andrea A.
    Beck-Coon, Kathleen A.
    Brown, Linda F.
    Wilhelm, Laura R.
    Monahan, Patrick O.
    LaPradd, Michelle L.
    Champion, Victoria L.
    Miller, Kathy D.
    Giesler, R. Brian
    CANCER, 2020, 126 (01) : 211 - 218
  • [5] ACCEPTANCE AND COMMITMENT THERAPY FOR CANCER SURVIVORS WITH FEAR OF RECURRENCE: RESULTS OF A 3-ARM RANDOMIZED CONTROLLED PILOT
    Johns, Shelley A.
    Cohee, Andrea A.
    Beck-Coon, Kathleen
    Brown, Linda
    LaPradd, Michelle L.
    Monahan, Patrick
    ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 : S791 - S792
  • [6] Fear of cancer recurrence among breast cancer survivors
    Ozakinci G.
    Sobota A.
    Humphris G.
    Current Breast Cancer Reports, 2014, 6 (3) : 219 - 225
  • [7] Trajectories of fear of cancer recurrence in young breast cancer survivors
    Schapira, Lidia
    Zheng, Yue
    Gelber, Shari
    Poorvu, Philip
    Ruddy, Kathryn J.
    Tamini, Rulla
    Peppercorn, Jeffrey
    Come, Steve
    Borges, Virginia
    Partridge, Ann
    Rosenberg, Shoshana
    CANCER RESEARCH, 2020, 80 (04)
  • [8] Trajectories of fear of cancer recurrence in young breast cancer survivors
    Schapira, Lidia
    Zheng, Yue
    Gelber, Shari, I
    Poorvu, Philip
    Ruddy, Kathryn J.
    Tamimi, Rulla M.
    Peppercorn, Jeffrey
    Come, Steven E.
    Borges, Virginia F.
    Partridge, Ann H.
    Rosenberg, Shoshana M.
    CANCER, 2022, 128 (02) : 335 - 343
  • [9] Fear of cancer recurrence and coping attitudes of breast cancer survivors
    Oztas, Bediye
    Ugurlu, Meltem
    Kurt, Gonul
    EUROPEAN JOURNAL OF CANCER CARE, 2022, 31 (06)
  • [10] Selective Attention and Fear of Cancer Recurrence in Breast Cancer Survivors
    Custers, J. A. E.
    Becker, E. S.
    Gielissen, M. F. M.
    Van Laarhoven, H. W. M.
    Rinck, M.
    Prins, J. B.
    ANNALS OF BEHAVIORAL MEDICINE, 2015, 49 (01) : 66 - 73